Ideaya Biosciences, Broad Institute Partner on Synthetic Lethality-Based Cancer Drug Discovery

Mar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Mar

Featured Webinar

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.

Menu

Ideaya Biosciences, Broad Institute Partner on Synthetic Lethality-Based Cancer Drug Discovery

To read the full story....

Breaking News

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

Fauna Bio Gets $373K NIH Grant to Study Animal Genomes for Potential Drug Targets

New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

In Brief This Week: Invenio Genetics, Swift Biosciences, Caris Life Sciences, and More

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Recent Headlines from
Precision Oncology News

MSK Study Finds Survival Gap Between Clinical Trial, Real-world Patients on Approved Cancer Drugs

McKesson-led Consortium to Establish Best Practices for Lung Cancer Molecular Testing, Treatment

After Setbacks, Innate Pharma on Track to Advance NK Cell-based Immunotherapy Pipeline

Cartesian Therapeutics Bets on mRNA Engineering for Moving CAR T Cells Into Frontline Treatment

Elicio Therapeutics Sharpens Development Plan for Cancer Vaccine in KRAS-Mutated Tumors

Featured White Papers

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

What's Popular?

Agilent Charges Into Liquid Biopsy Space with Resolution Biosciences Acquisition

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

C2i Genomics Acquires Sequencing Lab QNA Dx

Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy

Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

Sponsorships